The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

医学 非酒精性脂肪肝 内科学 荟萃分析 入射(几何) 流行病学 人口 脂肪肝 系统回顾 胃肠病学 人口学 梅德林 疾病 环境卫生 生物 光学 物理 社会学 生物化学
作者
Zobair M. Younossi,Pegah Golabi,James M. Paik,Austin Henry,Catherine Van Dongen,Linda Henry
出处
期刊:Hepatology [Wiley]
卷期号:77 (4): 1335-1347 被引量:829
标识
DOI:10.1097/hep.0000000000000004
摘要

Background and Aims: NAFLD is a leading cause of liver-related morbidity and mortality. We assessed the global and regional prevalence, incidence, and mortality of NAFLD using an in-depth meta-analytic approach. Approach and Results: PubMed and Ovid MEDLINE were searched for NAFLD population-based studies from 1990 to 2019 survey year (last published 2022) per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Meta-analysis was conducted using random-effects models. Bias risk assessment was per Joanna Briggs Institute. Of 2585 studies reviewed, 92 studies (N=9,361,716) met eligibility criteria. Across the study period (1990–2019), meta-analytic pooling of NAFLD prevalence estimates and ultrasound-defined NAFLD yielded an overall global prevalence of 30.05% (95% CI: 27.88%–32.32%) and 30.69% (28.4–33.09), respectively. Global NAFLD prevalence increased by +50.4% from 25.26% (21.59–29.33) in 1990–2006 to 38.00% (33.71–42.49) in 2016–2019 ( p <0.001); ultrasound-defined NAFLD prevalence increased by +38.7% from 25.16% (19.46–31.87) in 1990–2006 to 34.59% (29.05–40.57) ( p =0.029). The highest NAFLD prevalence was in Latin America 44.37% (30.66%–59.00%), then Middle East and North Africa (MENA) (36.53%, 28.63%–45.22%), South Asia (33.83%, 22.91%–46.79%), South-East Asia (33.07%, 18.99%–51.03%), North America (31.20%, 25.86%–37.08%), East Asia (29.71%, 25.96%–33.76%), Asia Pacific 28.02% (24.69%–31.60%), Western Europe 25.10% (20.55%–30.28%). Among the NAFLD cohort diagnosed without a liver biopsy, pooled mortality rate per 1000 PY was 12.60 (6.68–23.67) for all-cause mortality; 4.20 (1.34–7.05) for cardiac-specific mortality; 2.83 (0.78–4.88) for extrahepatic cancer-specific mortality; and 0.92 (0.00–2.21) for liver-specific mortality. Conclusions: NAFLD global prevalence is 30% and increasing which requires urgent and comprehensive strategies to raise awareness and address all aspects of NAFLD on local, regional, and global levels.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
鬼才之眼完成签到,获得积分10
刚刚
Fury发布了新的文献求助10
1秒前
ccq发布了新的文献求助10
1秒前
yanxueyi完成签到 ,获得积分10
2秒前
清醒完成签到,获得积分10
4秒前
共享精神应助wang采纳,获得10
5秒前
6秒前
7秒前
7秒前
calm完成签到,获得积分20
8秒前
11秒前
11秒前
quanjia发布了新的文献求助10
12秒前
啦啦啦发布了新的文献求助10
12秒前
14秒前
15秒前
15秒前
巫马小霜发布了新的文献求助20
17秒前
wang发布了新的文献求助10
18秒前
布洛芬发布了新的文献求助10
19秒前
Singularity应助甜甜采纳,获得10
20秒前
bestbanana发布了新的文献求助10
20秒前
刻苦小丸子完成签到,获得积分10
20秒前
wnche完成签到,获得积分10
21秒前
上官若男应助爱睡午觉采纳,获得10
21秒前
万能图书馆应助清醒采纳,获得10
22秒前
和谐小南完成签到,获得积分10
23秒前
司徒不二完成签到,获得积分0
24秒前
24秒前
在水一方应助kissssp采纳,获得10
29秒前
Fa完成签到,获得积分10
31秒前
31秒前
32秒前
Dado完成签到,获得积分10
32秒前
32秒前
xiaowu完成签到,获得积分10
32秒前
今后应助quanxia采纳,获得10
32秒前
俭朴依白完成签到,获得积分10
33秒前
爱睡午觉发布了新的文献求助10
37秒前
清爽泥猴桃完成签到,获得积分10
39秒前
高分求助中
Sustainability in Tides Chemistry 2800
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Handbook of Qualitative Cross-Cultural Research Methods 600
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137539
求助须知:如何正确求助?哪些是违规求助? 2788516
关于积分的说明 7787114
捐赠科研通 2444837
什么是DOI,文献DOI怎么找? 1300071
科研通“疑难数据库(出版商)”最低求助积分说明 625796
版权声明 601023